Home » Samsung Biologics buys Swiss peptide maker for $1.8bn
FinancIal Times

Samsung Biologics buys Swiss peptide maker for $1.8bn

by External Source

PolyPeptide takeover is latest example of South Korean companies expanding abroad through acquisitionsOriginal Article

Africa News Matters is powered by the Colorado non-profit Africa Agenda. We credit our sources via link sharing. Support us, make a donation today!

You may also like

Investors fear Japanese bond bets risk becoming new...

Trump plans 100% tariffs on generic drugs in...

OpenAI admits an AI ‘agent’ caused a major...

Trump taps Big Tech critic as chief of...

Japan’s trains are getting much faster as moonshot...

MPs call on Burnham to extend employer tax...

Trump reinstates direct US flights to Lebanon after...

US Treasury sends warning to hedge funds over...

Zelenskyy replaces top Ukraine general in biggest military...

Trump vows to attack Iranian nuclear facility as...

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
@2026 Africa Agenda. All Rights Reserved.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More